CoChat

Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study

Open access
Chhatwal, Jasmeer P, Schultz, Stephanie A, McDade, Eric, Schultz, Aaron P, Liu, Lei, Hanseeuw, Bernard J, Joseph-Mathurin, Nelly, Feldman, Rebecca, Fitzpatrick, Colleen D, Sparks, Kathryn P, Levin, Johannes, Berman, Sarah B, Renton, Alan E, Esposito, Bianca T, Fernandez, Maria Vitoria, Sung, Yun Ju, Lee, Jae Hong, Klunk, William E, Hofmann, Anna, Noble, James M, Graff-Radford, Neill, Mori, Hiroshi, Salloway, Steven M, Masters, Colin L, Martins, Ralph, Karch, Celeste M, Xiong, Chengjie, Cruchaga, Carlos, Perrin, Richard J, Gordon, Brian A, Benzinger, Tammie L S, Fox, Nick C, Schofield, Peter R, Fagan, Anne M, Goate, Alison M, Morris, John C, Bateman, Randall J, Johnson, Keith A, Sperling, Reisa A · 2022 · The Lancet Neurology
Cited by 72

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Background: Examination of autosomal dominant Alzheimer’s disease has broadly influenced mechanistic hypotheses, biomarker development, and clinical trials in both sporadic and dominantly-inherited Alzheimer’s disease. While pathogenic variants causing autosomal dominant Alzheimer’s disease are highly-penetrant, there is substantial heterogeneity in β-amyloid levels across individuals. We examined whether this heterogeneity is related to disease progression and its association with mutation location within PSEN1, PSEN2, or APP. Methods: We examined variant-dependent variability in Pittsburgh-Compound-B PET (PiB-PET) signal, CSF Aβ42 and Aβ40 in 347 participants (206 carriers) in the Dominantly Inherited Alzheimer’s Network Observational Study assessed from 2008 to 2019. Two approaches were used to group the 62 unique pathogenic variants in the cohort: (1) based on affected protein domain in PSEN1, PSEN2, or APP, and (2) based on whether PSEN1 variants were before or after codon 200. Findings: Cortical and striatal PiB-PET signal demonstrated striking variant-dependent variability using both grouping approaches, despite similar progression on the Clinical Dementia Rating and CSF Aβ42 levels. Longitudinal PiB-PET signal also varied across codon-based groups, mirroring cross-sectional analyses. Interpretation: Autosomal dominant Alzheimer’s disease pathogenic variants demonstrated highly differential temporal and regional patterns of β-amyloid PET, despite similar functional progression. This suggests that while increased β-amyloid PET signal is generally seen in autosomal dominant Alzheimer’s disease, higher levels of β-amyloid PET signal at an individual level may not reflect more severe or more advanced disease – an important consideration for ongoing clinical trials, including those using β-amyloid PET as a surrogate measure of disease progression. Also germane to both sporadic and autosomal dominant Alzheimer’s disease, the results here suggest CSF and PET measures of β-amyloid levels are not interchangeable and may reflect different amyloid-driven pathobiological processes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(21)00375-6

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 72

Metadata

Authors
Chhatwal, J. P., Schultz, S. A., McDade, E., Schultz, A. P., Liu, L., Hanseeuw, B. J., Joseph-Mathurin, N., Feldman, R., Fitzpatrick, C. D., Sparks, K. P., Levin, J., Berman, S. B., Renton, A. E., Esposito, B. T., Fernandez, M. V., Sung, Y. J., Lee, J. H., Klunk, W. E., Hofmann, A., Noble, J. M., Graff-Radford, N., Mori, H., Salloway, S. M., Masters, C. L., Martins, R., Karch, C. M., Xiong, C., Cruchaga, C., Perrin, R. J., Gordon, B. A., Benzinger, T. L. S., Fox, N. C., Schofield, P. R., Fagan, A. M., Goate, A. M., Morris, J. C., Bateman, R. J., Johnson, K. A., & Sperling, R. A.
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2022-02
Volume
21
Issue
2
Pages
140-152
ISSN
1474-4422 (ISSN-L)
OpenAlex
W4205319604
Cited by
72
References
16
FWCI
8.21
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study. https://app.cochat.ai/papers/10.1016/s1474-4422(21)00375-6
The paper
Chhatwal, J. P., Schultz, S. A., McDade, E., Schultz, A. P., Liu, L., Hanseeuw, B. J., Joseph-Mathurin, N., Feldman, R., Fitzpatrick, C. D., Sparks, K. P., Levin, J., Berman, S. B., Renton, A. E., Esposito, B. T., Fernandez, M. V., Sung, Y. J., Lee, J. H., Klunk, W. E., Hofmann, A., . . . Sperling, R. A. (2022). Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(21)00375-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.